lilly glp 1 small molecule Eli Lilly's orforglipron: a new oral GLP-1 therapy | Thomas Fessard posted on the topic A new class of oral

GLP 1 & GIP therapy works by reducing appetite, slowing digestion, and regulating and lowering blood sugar

The weakened barrier also makes the skin more susceptible to further environmental damage and allergen penetration

, , ,

It is possible to have a combination of these different pharmacologies in a unimolecular drug, as GLP-1, GIP, and glucagon all share the same secondary structure as well as a conserved region of amino acids

Knock-down of glutaminase 2 expression decreases glutathione, NADH, and sensitizes cervical cancer to ionizing radiation

Supporting Hair Growth: Encouraging follicle health and hair restoration